AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
175.58
+4.06 (2.37%)
Dec 20, 2024, 4:01 PM EST - Market closed
AbbVie Employees
AbbVie had 50,000 employees as of January 31, 2024. The number of employees did not change compared to the previous year.
Employees
50,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,110,660
Profits / Employee
$101,620
Market Cap
310.27B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 50,000 | 0 | - |
Jan 31, 2023 | 50,000 | 0 | - |
Jan 31, 2022 | 50,000 | 3,000 | 6.38% |
Jan 31, 2021 | 47,000 | 17,000 | 56.67% |
Jan 31, 2020 | 30,000 | 0 | - |
Jan 31, 2019 | 30,000 | 1,000 | 3.45% |
Jan 31, 2018 | 29,000 | -1,000 | -3.33% |
Jan 31, 2017 | 30,000 | 2,000 | 7.14% |
Jan 31, 2016 | 28,000 | 2,000 | 7.69% |
Jan 31, 2015 | 26,000 | 1,000 | 4.00% |
Jan 31, 2014 | 25,000 | 3,500 | 16.28% |
Jan 31, 2013 | 21,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ABBV News
- 2 days ago - Retirement-Ready Income: 5 Dividend Gems I'd Buy If I Were 65 - Seeking Alpha
- 3 days ago - My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 Buys - Seeking Alpha
- 3 days ago - Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo - Business Wire
- 4 days ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 4 days ago - AbbVie: Pullback Is A Golden Opportunity For Dividend And Growth Investors - Seeking Alpha
- 5 days ago - AbbVie Enters Oversold Territory - Forbes
- 7 days ago - Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value - Seeking Alpha
- 8 days ago - AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline - PRNewsWire